High Outlier
Strength
250 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092018981
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
MESALAMINEApproval Type
New Drug (NDA)
FDA Application
NDA020049On Market Since
5/10/1993
Pharmacological Classes
Aminosalicylate
Aminosalicylic Acids
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.